Eflornithine Clinical Trials
3 recruitingDrug
Phase 22Early Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 2
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
OsteosarcomaEwing SarcomaEwing Sarcoma Metastatic
Milton S. Hershey Medical Center406 enrolled2 locationsNCT07321912
Recruiting
Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Giselle Sholler131 enrolled31 locationsNCT04301843
Recruiting
Early Phase 1
Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma
Diffuse GliomaMalignant Glioma
Mayo Clinic18 enrolled1 locationNCT05717153